发明名称 GLP-1 AND METHODS FOR TREATING DIABETES.
摘要 <p>The present invention relates to use of GLP-1 or a related molecule having GLP-effect for the manufacture of a medicament for preventing or treating diabetes in a mammal. The amount and timing of administration of said medicament are subsequently reduced to produce a "drug holiday". Practice of the invention achieves effective therapy without continuous drug exposure and without continuous presence of therapeutic levels of the drug. The invention also discloses a method of treating diabetes and related disorders in a mammal by administering glucagon like peptide (GLP-1) or a related molecule having GLP-1 like effect and thereby providing a therapeutically effective amount of endogenous insulin.</p>
申请公布号 MXPA04012497(A) 申请公布日期 2005.07.14
申请号 MX2004PA12497 申请日期 2003.07.02
申请人 ZEALAND PHARMA A/S 发明人 EVA STEINESS
分类号 A61K38/22;A61K38/26;A61K38/28;A61K38/31;A61P3/10;(IPC1-7):A61K38/26;A61K47/48;C07K14/575;C07K14/605;C12N5/06 主分类号 A61K38/22
代理机构 代理人
主权项
地址
您可能感兴趣的专利